RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,529,921 | -43.4% | 657,541 | -15.4% | 0.00% | 0.0% |
| Q2 2023 | $9,764,986 | +5.5% | 777,467 | +38.3% | 0.00% | 0.0% |
| Q1 2023 | $9,258,347 | -73.8% | 562,134 | -76.3% | 0.00% | -75.0% |
| Q4 2022 | $35,397,999 | +362.2% | 2,369,344 | +592.1% | 0.00% | +300.0% |
| Q3 2022 | $7,658,000 | -27.0% | 342,341 | -45.3% | 0.00% | 0.0% |
| Q2 2022 | $10,487,000 | -18.8% | 626,124 | +45.1% | 0.00% | -50.0% |
| Q1 2022 | $12,915,000 | -19.7% | 431,480 | -17.6% | 0.00% | 0.0% |
| Q4 2021 | $16,076,000 | +14.1% | 523,493 | +17.2% | 0.00% | 0.0% |
| Q3 2021 | $14,087,000 | -32.4% | 446,791 | -21.6% | 0.00% | -33.3% |
| Q2 2021 | $20,843,000 | +22.9% | 569,645 | +16.1% | 0.00% | +50.0% |
| Q1 2021 | $16,960,000 | +217.0% | 490,608 | +281.0% | 0.00% | +100.0% |
| Q4 2020 | $5,351,000 | +20.4% | 128,759 | +23.4% | 0.00% | 0.0% |
| Q3 2020 | $4,443,000 | – | 104,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |